LobbyingStoke Therapeutics lobbying by quarter
Stoke Therapeutics STOK's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Stoke TherapeuticsSTOK
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$190K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ferox Strategies | $180K | 5 quarters |
| W Strategies | $30K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MARK WILLIAMS | Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson. | Q3 2025 |
| MICHAEL TAGGART | Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director | Q3 2025 |
| DARREN WILLCOX | Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Ferox Strategies | $40K |
| 04/17for Q1 | Ferox Strategies | $40K |
| 01/20for Q4 2025 | Ferox Strategies | $40K |
| 25/10/20for Q3 2025 | Ferox Strategies | $40K |
| 25/07/18for Q2 2025 | Ferox Strategies | $20K |
| 25/07/07for Q2 2025 | Ferox Strategies | Under $5,000 |
| 23/01/19for Q4 2022 | W Strategies | $30K |